Nipro Corporation (TYO:8086)

Market Cap	263.73B +20.5%
Revenue (ttm)	652.61B +4.1%
Net Income	15.20B +199.6%
EPS	82.58 +199.6%
Shares Out	163.10M
PE Ratio	19.58
Forward PE	18.45
Dividend	28.00 (1.73%)
Ex-Dividend Date	Mar 30, 2026

Volume	444,000
Average Volume	807,215
Open	1,622.00
Previous Close	1,635.00
Day's Range	1,616.00 - 1,632.50
52-Week Range	1,230.50 - 1,664.00
Beta	-0.02
RSI	56.09
Earnings Date	May 12, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1947
• Employees: 39,168
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 8086

Financial Performance

In fiscal year 2025, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.